Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance (Q34827434)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance |
scientific article |
Statements
1 reference
Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance (English)
1 reference
K Toutouzas
1 reference
M Riga
1 reference
E Stefanadi
1 reference
C Stefanadis
1 reference
15 September 2008
1 reference
1 reference
Identifiers
1 reference